The term 'catastrophic'antiphospholipid syndrome (APS) is used to define an accelerated
form of APS resulting in multiorgan failure. Although catastrophicAPS patients represent less …

The term “antiphospholipid syndrome”(APS) was introduced to describe patients presenting
with a combination of recurrent arterial and venous throm-bosis, recurrent fetal losses, often …

The antiphospholipid syndrome (APS), originally defined as the combination of venous or
arterial thrombotic events, recurrent fetal loss, and, frequently, a moderate thrombocytopenia …

ASHERSON, RONALD AMD, FACP, FCP,(SA) 1; KHAMASHTA, MUNTHER AMD 1; ORDI-
ROS, JOSE MD 3; DERKSEN, RONALD HWMMD 2; MACHIN, SAMUEL JMD, FRC PATH. 4; …

Quantitative isotype specific enzyme linked immunosorbent assay (ELISA) was used to
determine the distribution of immunoglobulin isotypes and phospholipid specificities of …

• To determine the predictive value of the IgG anticardiolipin antibody (ACA) test for
thrombosis, recurrent fetal loss, and thrombocytopenia, the clinical features of 121 patients …

A prospective echocardiographic study was carried out on 132 consecutive patients with
systemic lupus erythematosus (SLE) derived from three European university medical …

Objective To assess the main causes of death and the prognostic factors that influence
mortality in patients with the catastrophic antiphospholipid syndrome (CAPS). Methods We …

Many infections have been found to be associated with antiphospholipid antibodies (aPL),
although a pathogenic role for these antibodies has not usually been obvious except in a …

Objective: To describe the characteristics of patients with catastrophic antiphospholipid
syndrome (APS) included in the International Registry of patients with this condition (CAPS …